Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesRisk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
Infection Control and Hospital Epidemiology, 10/28/09
Gasink LB et al. – KPC–producing K. pneumoniae is an emerging pathogen associated with significant mortality. The findings highlight the urgent need to develop strategies for prevention and infection control. Limiting use of certain antimicrobials, specifically fluoroquinolones and cephalosporins, use may be effective strategies.
Related Articles
Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae
Journal of Medical Microbiology, 10/21/09
Relevance Score: 69%
Interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae : the roles of capsule and LPS O-antigen unravelled
Infection and Immunity, 10/29/09
Relevance Score: 67%
Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth of Klebsiella Pneumoniae and Aeromonas Hydrophila Isolated from Transfusion-Dependent Thalassemia Patients
Hemoglobin, 10/23/09
Relevance Score: 66%
OxyR, a LysR-type regulator involved in Klebsiella pneumoniae mucosal and abiotic colonization
Infection and Immunity, 10/06/09
Relevance Score: 66%
Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center
American Journal of Infection Control, 11/12/09
Relevance Score: 65%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
The Lancet, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Associations between HLA Class I Alleles and Escape Mutations in the Hepatitis B Virus Core Gene in New Zealand-Resident Tongans
Journal of Virology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor